As of 2025-06-22, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (1.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.64 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -135.0%.
The range of the Relative Valuation is (1.57) - (2.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 23.4x | 19.2x |
| Forward P/E multiples | 16.5x - 27.9x | 22.2x |
| Fair Price | (1.57) - (2.23) | (1.97) |
| Upside | -127.9% - -139.6% | -135.0% |
| Date | P/E |
| 2025-06-18 | -60.07 |
| 2025-06-17 | -60.80 |
| 2025-06-16 | -63.42 |
| 2025-06-13 | -63.22 |
| 2025-06-12 | -64.68 |
| 2025-06-11 | -64.37 |
| 2025-06-10 | -64.05 |
| 2025-06-09 | -63.22 |
| 2025-06-06 | -64.58 |
| 2025-06-05 | -62.48 |
| 2025-06-04 | -63.95 |
| 2025-06-03 | -65.63 |
| 2025-06-02 | -64.58 |
| 2025-05-30 | -63.63 |
| 2025-05-29 | -65.10 |
| 2025-05-28 | -63.95 |
| 2025-05-27 | -65.42 |
| 2025-05-23 | -65.21 |
| 2025-05-22 | -65.63 |
| 2025-05-21 | -66.46 |
| 2025-05-20 | -69.09 |
| 2025-05-19 | -67.30 |
| 2025-05-16 | -67.41 |
| 2025-05-15 | -62.38 |
| 2025-05-14 | -61.64 |
| 2025-05-13 | -63.11 |
| 2025-05-12 | -65.10 |
| 2025-05-09 | -62.69 |
| 2025-05-08 | -63.74 |
| 2025-05-07 | -63.84 |
| 2025-05-06 | -64.89 |
| 2025-05-05 | -68.46 |
| 2025-05-02 | -69.92 |
| 2025-05-01 | -70.03 |
| 2025-04-30 | -80.51 |
| 2025-04-29 | -78.84 |
| 2025-04-28 | -77.47 |
| 2025-04-25 | -77.05 |
| 2025-04-24 | -75.48 |
| 2025-04-23 | -74.43 |
| 2025-04-22 | -72.44 |
| 2025-04-21 | -70.34 |
| 2025-04-17 | -71.60 |
| 2025-04-16 | -70.24 |
| 2025-04-15 | -72.34 |
| 2025-04-14 | -70.45 |
| 2025-04-11 | -67.93 |
| 2025-04-10 | -68.25 |
| 2025-04-09 | -72.23 |
| 2025-04-08 | -70.45 |